首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1335568篇
  免费   95972篇
  国内免费   2910篇
耳鼻咽喉   19720篇
儿科学   40247篇
妇产科学   38719篇
基础医学   187405篇
口腔科学   39896篇
临床医学   112726篇
内科学   262566篇
皮肤病学   30211篇
神经病学   106508篇
特种医学   53700篇
外国民族医学   435篇
外科学   208444篇
综合类   31051篇
现状与发展   6篇
一般理论   436篇
预防医学   92149篇
眼科学   31362篇
药学   100159篇
  4篇
中国医学   2988篇
肿瘤学   75718篇
  2018年   11766篇
  2015年   11895篇
  2014年   16731篇
  2013年   25292篇
  2012年   33084篇
  2011年   34951篇
  2010年   20775篇
  2009年   20262篇
  2008年   33653篇
  2007年   36744篇
  2006年   37311篇
  2005年   36063篇
  2004年   35143篇
  2003年   34102篇
  2002年   33648篇
  2001年   63654篇
  2000年   65356篇
  1999年   55417篇
  1998年   14658篇
  1997年   13474篇
  1996年   12948篇
  1995年   12231篇
  1994年   11479篇
  1992年   42783篇
  1991年   41301篇
  1990年   40579篇
  1989年   39571篇
  1988年   36980篇
  1987年   36429篇
  1986年   34910篇
  1985年   33112篇
  1984年   24834篇
  1983年   21063篇
  1982年   12669篇
  1981年   11573篇
  1980年   10776篇
  1979年   23932篇
  1978年   17074篇
  1977年   14839篇
  1976年   13389篇
  1975年   15273篇
  1974年   18089篇
  1973年   17568篇
  1972年   16815篇
  1971年   15718篇
  1970年   14918篇
  1969年   14348篇
  1968年   13464篇
  1967年   12018篇
  1966年   11262篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
32.
33.
34.
35.
36.
37.
38.
AimsThe aims were to 1) develop the pharmacokinetics model to describe and predict observed tanezumab concentrations over time, 2) test possible covariate parameter relationships that could influence clearance and distribution and 3) assess the impact of fixed dosing vs. a dosing regimen adjusted by body weight.MethodsIndividual concentration–time data were determined from 1608 patients in four phase 3 studies conducted to assess efficacy and safety of intravenous tanezumab. Patients received two or three intravenous doses (2.5, 5 or 10 mg) every 8 weeks. Blood samples for assessment of tanezumab PK were collected at baseline, 1 h post‐dose and at weeks 4, 8, 16 and 24 (or early termination) in all studies. Blood samples were collected at week 32 in two studies. Plasma samples were analyzed using a sensitive, specific, validated enzyme‐linked immunosorbent assay.ResultsA two compartment model with parallel linear and non‐linear elimination processes adequately described the data. Population estimates for clearance (CL), central volume (V 1), peripheral volume (V 2), inter‐compartmental clearance, maximum elimination capacity (VM) and concentration at half‐maximum elimination capacity were 0.135 l day–1, 2.71 l, 1.98 l, 0.371 l day–1, 8.03 μg day–1 and 27.7 ng ml–1, respectively. Inter‐individual variability (IIV) was included on CL, V 1, V 2 and VM. A mixture model accounted for the distribution of residual error. While gender, dose and creatinine clearance were significant covariates, only body weight as a covariate of CL, V 1 and V 2 significantly reduced IIV.ConclusionsThe small increase in variability associated with fixed dosing is consistent with other monoclonal antibodies and does not change risk : benefit.  相似文献   
39.
40.
INTRODUCTIONPsoriasis is a chronic inflammatory condition that affects the skin and joints, and is associated with cardiovascular risk factors, including metabolic syndrome (MetS). We aimed to assess the prevalence of MetS in patients with psoriasis and determine whether there was a correlation between psoriasis severity and MetS in a Singapore population.METHODSThis was a cross-sectional study of patients with psoriasis, aged 18–69 years, who attended a tertiary dermatology referral centre in Singapore from October 2007 to February 2009. Fasting glucose, lipids, blood pressure, Psoriasis Area and Severity Index, and body mass index were measured. MetS was diagnosed in the presence of three or more criteria of the modified National Cholesterol Education Program Adult Treatment Panel III.RESULTSAmong 338 patients with psoriasis, there were 238 (70.4%) men and 100 (29.6%) women, who were Chinese (n = 228; 67.5%), Malay (n = 52; 15.4%) and Indian (n = 58; 17.2%). The prevalence of MetS was 45.1%. MetS was 44% more prevalent in patients older than 50 years (p = 0.02). Malay patients with psoriasis were significantly more likely to have hypertriglyceridaemia, elevated fasting plasma glucose and abdominal obesity. There was no significant correlation between psoriasis severity and risk of MetS.CONCLUSIONThe prevalence of MetS in patients with psoriasis in Singapore was 45.1%, or nearly threefold higher than the Singapore general population. Patients with psoriasis should be screened yearly for MetS and any modifiable cardiovascular risk factors should be actively controlled.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号